Kinetic and conformational studies of adenosine deaminase upon interaction with oxazepam and lorazepam

Protein and Peptide Letters

Volumn 17, Issue 2, 2010, Pages 197-205

  Moosavi Movahedi, A A ^a,b   Tehrani, H Sepassi ^a   Amanlou, M ^c   Soltani Rad, M N ^d   Hakimelahi, G H ^e   Tsai, F Y ^f   Ataie, G ^a   Saboury, A A ^a   Ahmad, F ^g   Khalafi Nezhad, A ^h   Poursasan, N ^a   Sharifizadeh, A ^a  

^a UNIVERSITY OF TEHRAN   (Iran)

^b Foundation for Advancement of Science and Technology in Iran FAST IR   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF TECHNOLOGY   (Iran)

^e TaiGen Biotechnology   (Taiwan)

^f CHANG GUNG UNIVERSITY   (Taiwan)

^g JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

^h SHIRAZ UNIVERSITY   (Iran)

Author keywords

Adenosine deaminase; Kinetics; Lorazepam; Oxazepam; Structures

Indexed keywords

ADENOSINE; ADENOSINE DEAMINASE; ANTICONVULSIVE AGENT; ANXIOLYTIC AGENT; ENZYME INHIBITOR; HYPNOTIC SEDATIVE AGENT; LIGAND; LORAZEPAM; OXAZEPAM;

ANIMAL; ARTICLE; CATTLE; CHEMICAL STRUCTURE; CHEMISTRY; CIRCULAR DICHROISM; COMPARATIVE STUDY; COMPUTER SIMULATION; DRUG ANTAGONISM; ENZYMOLOGY; INTESTINE MUCOSA; KINETICS; METABOLISM; PROTEIN CONFORMATION; SPECTROFLUOROMETRY; STRUCTURE ACTIVITY RELATION; TEMPERATURE;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; ANTI-ANXIETY AGENTS; ANTICONVULSANTS; CATTLE; CIRCULAR DICHROISM; COMPUTER SIMULATION; ENZYME INHIBITORS; HYPNOTICS AND SEDATIVES; INTESTINAL MUCOSA; KINETICS; LIGANDS; LORAZEPAM; MODELS, MOLECULAR; OXAZEPAM; PROTEIN CONFORMATION; SPECTROMETRY, FLUORESCENCE; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE;

EID: 77949956630     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986610790226076     Document Type: Article

References (31)

1. Hirshhorn, R.; Ratech, H.; In Isoenzymes of adenosine deaminase. In Isoenzymes: Current Topics in Biological and Medical Research, Rattazzi M.C.; Scandalios J.G.; Whitt G.S. Eds., Alan RLiss: New York, 1980; Vol. 4, pp. 131-157.
2. Wilson, D.K.; Rudolph, F.B.; Quiocho F.A. Atomic structure of adenosine deaminase complexed with a transition-state analog: understanding catalysis and immunodeficiency mutations. Science,1991, 252(5010), 1278-1284.
3. Dong, R.P.; Kameoka, J.; Hegen, M.; Tanaka, T.; Xu, T.H.; Schlossman, S.F.; Morimoto, C. Characterization of adenosinedeaminase binding to human CD26 on T cells and its biologic rolein immune response. J. Immunol., 1996, 156(4), 1349-1355.
4. Hershfield, M.S.; Mitchell, B.S. In The metabolic and molecularbasis of inherited disease, Scriver C.R.; Beaudet A.L.; Sly W.S.;Valle D. Eds.; McGraw-Hill, Inc.: New York, 1995; 7th ed. Vol. 1,pp. 1725-1768.
5. Hershfield, M.S. Adenosine deaminase deficiency: clinical expression, molecular basis and therapy. Semin. Hematol., 1998, 35(4),291-298.
6. Cassani, B.; Mirolo, M.; Cattaneo, F.; Benninghoff, U.; Hershfield, M., Carlucci, F.; Tabucchi, A.; Bordignon, C.; Roncarolo, M.G.; Aiuti, A. Altered intracellular and extracellular signaling leads toimpaired T-cell functions in ADA-SCID patients. Blood, 2008,111(8), 4209-4219.
7. Gan, T.E.; Dadonna, P.E.; Mitchell, B.S. Genetic expression ofadenosine deaminase in human lymphoid malignancies. Blood,1987, 69 (5), 1376-1380.
8. Hong, L.; Mulholland, J.; Chinsky, J.M.; Knudsen, T.B. Develop-mental expression of adenosine deaminase during decidualizationin the rat uterus. Biol. Repord., 1991, 44(1), 83-93.
9. Phillis, J.W.; Wu, P.H. The role of adenosine and its nucleotides incentral synaptic transmission. Prog. Neurobiol., 1981, 16(3-4),187-239.
10. Barchi, J.J.; Marquez, V.E.; Driscoll, J.S.; Ford, H.; Mitsuya, H.; Shirasaka, T., Aoki, S.; Kelly, J. Potential anti-AIDS drugs. Lipophilic, adenosine deaminase-activated prodrugs. J. Med. Chem.,1991, 34(5), 1647-1655.
11. Ford, H.; Siddiqui, M.A.; Driscoll, J.S.; Marquez, V.E.; Kelly J.A.; Mitsuya, H.; Shirasaka, T. Lipophilic, acid-stable, adenosinedeaminase-activated anti-HIV prodrugs for central nervous systemdelivery. 2. 6-Halo and 6-alkoxy prodrugs of 2'-beta-fluoro-2',3'-dideoxyinosine. J. Med. Chem., 1995, 38(7), 1189-1195.
12. Doddona, P.E.; Schewach, D.S.; Kelly, W.N.; Argos, P.; Markham, A.F.; Orkin, S.H. Human adenosine deaminase. cDNA and complete primary amino acid sequence. Biol. Chem., 1984, 259(19),12101-12106.
13. Chang, Z.; Nygaard, P.; Chinualt, A.C.; Kellems, R.E. Deducedamino acid sequence of Escherichia coli adenosine deaminase reveals evolutionarily conserved amino acid residues: implicationsfor catalytic function. Biochemistry, 1991, 30(8), 2275-2280.
14. Wilson, D.K.; Quiocho, F.A. A pre-transition-state mimic of anenzyme: X-ray structure of adenosine deaminase with bound 1-deazaadenosine and zinc-activated water. Biochemistry, 1993,32(7), 1689-1694.
15. Moosavi-Movahedi, A.A.; Safarian, S.; Hakimelahi, G.H.; Ataei, G.; Ajloo, D.; Panjehpour, S.; Riahi, S.; Mousavi, M.F.; Mardanyan, S.; Soltani Rad, M.N.; Khalafi-Nezhad, A.; Sharghi, H.; Moghadamnia, H.; Saboury A.A. QSAR analysis for adenosinedeaminase upon interaction with a series of adenine derivatives asinhibitors. Nucleosides Nucleotides Nucleic Acids, 2004, 23(3),613-624.
16. Bhaumik, D.; Medin, J.; Gathy, K.; Coleman, M.S. Mutationalanalysis of active site residues of human adenosine deaminase. J.Biol. Chem., 1993, 268(8), 5464-5470.
17. Alunni, S.; Orru, M.; Ottavi, L. A study on the inhibition of adenosine deaminase. J. Enzyme. Inhib. Med. Chem., 2008, 23(2), 182-189.
18. Saboury, A.A.; Bagheri, S.; Ataie, G.; Amanlou, M.; Moosavi-Movahedi, A.A.; Hakimelahi, G.H.; Cristalli, G.; Namaki, S. Binding properties of adenosine deaminase interacted with theophylline. Chem. Pharm. Bull., 2004, 52(10), 1179-1182.
19. Sheid, B. Trazodone a nontricyclic antidepressant, is an inhibitor of adenosine deaminase. Res. Commun. Chem. Pathol. Pharmacol.,1985, 47(1), 149-152.
20. Kaplan, N.O. Specific adenosine deaminase from intestine. Methods Enzymol., 1955; Vol. 2, 473-475.
21. Alessandrini, L.; Ciuffreda, P.; Pavlovic, R.; Santaniello, E. Activity of adenosine deaminase and adenylate deaminase on adenosineand 2', 3'-isopropylidene adenosine: Role of the protecting group atdifferent pH values. Nucleosides Nucleotides Nucleic Acids, 2008,27(1), 31-36.
22. Yang, J.T.; Wu, C.S.C.; Martinez, H.M. Calculation of proteinconformation from circular dichroism. Methods Enzymol., 1986,Vol. 130, 208-269.
23. Hennessey, J.P., Jr; Johnson, W.C., Jr. Experimental errors andtheir effect on analyzing circular dichroism spectra of proteins. Anal. Biochem., 1982, 125(1), 177-188.
24. Saboury, A.A; Divsalar, A.; Ataie, G.; Amanlou, M., Moosavi-Movahedi, A.A.; Hakimelahi, G.H. Inhibition study of adenosinedeaminase by caffeine using spectroscopy andisothermal titrationcalorimetry. Acta. Biochim. Polonica, 2003, 50(30), 849-855.
25. Ataie, G.; Safarian, S.; Divsalar, A.; Saboury, A.A.; Moosavi-Movahedi, A.A.; Ranjbar, B.; Cristalli, G.; Mardanian, S. Kineticand structural analysis of the inhibition of adenosine deaminase byacetaminophen. J. Enzyme. Inhib. Med. Chem., 2004, 19(1), 71-78.
26. Morris, G.M.; Goodsell, D.S.; Halliday, R.S.; Huey, R.; Hart, W.E.; Belew, R.K.; Olson, A.J. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem., 1998, 19(14), 1639-1662.
27. Sayle, R.; Milner-White, E.J. RasMol: biomolecular graphics forall. Trends Biochem. Sci. (TIBS), 1995, 20(9), 374.
28. Tamura, T.; Oki, Y.; Yoshida, A.; Kuriyama, T.; Kawakami, H.; Inoue, H.; Inagaki, K.; Tanaka, H. Noncompetitive, reversible inhibition of aminoacylase-1 by a series of L-alpha-hydroxyl and L-alpha-fluoro fatty acids: ligand specificity of aspergillus oryzae andporcine kidney enzymes. Arch. Biochem. Biophys., 2000, 379(2),261-266.
29. Ahmed, S.; James, K.; Owen, C.P.; Patel, C.K.; Patel, M. Hydro-phobicity, a physicochemical factor in the inhibition of the enzymeestrone sulfatase. Bioorg. Med. Chem. Lett., 2001, 11(18), 2525-2528.
30. Flanagan, R.J. Guidelines for the interpretation of analytical toxicology results and unit of measurement conversion factors. Ann. Clin. Biochem., 1998, 35(Pt 2), 261-267.
31. Molero-Monfort, M.; Sagrado, S.; Villanueva-Camanas, R.M; Medina-Hernandez, M.J. Retention-activity relationship studies of benzodiazepines by micellar liquid chromatography. Biomed. Chromatogr., 1999, 13(6), 394-400.